資料載入中.....
|
請使用永久網址來引用或連結此文件:
https://ir.cnu.edu.tw/handle/310902800/34348
|
| 標題: | Gene signatures and potential therapeutic targets of Middle East respiratory syndrome coronavirus (MERS-CoV)-infected human lung adenocarcinoma epithelial cells |
| 作者: | Wu, Yen-Hung
Yeh, I-Jeng
Phan, Nam Nhut
Yen, Meng-Chi
Hung, Jui-Hsiang
Chiao, Chung-Chieh
Chen, Chien-Fu
Sun, Zhengda
Hsu, Hui-Ping
Wang, Chih-Yang
Lai, Ming-Derg |
| 貢獻者: | Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Emergency Med
Kaohsiung Med Univ, Coll Med, Grad Inst Clin Med
Nguyen Tat Thanh Univ, NTT Inst Hitechnol
Chia Nan Univ Pharm & Sci, Dept Biotechnol
I Shou Univ, Sch Chinese Med Postbaccalaureate
Kaiser Permanente, Northern Calif Reg Labs, Permanente Med Grp
Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Surg
Vanderbilt Univ, Dept Biostat, Med Ctr
Taipei Med Univ, Coll Med Sci & Technol, PhD Program Canc Mol Biol & Drug Discovery
Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Canc Biol & Drug Discovery
Natl Cheng Kung Univ, Dept Biochem & Mol Biol
Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci |
| 關鍵字: | Coronavirus
Middle East respiratory syndrome coronavirus (MERS-CoV)
miRNA
Bioinformatics
Connectivity map
Lung adenocarcinoma |
| 日期: | 2021 |
| 上傳時間: | 2023-11-11 11:45:00 (UTC+8) |
| 出版者: | ELSEVIER TAIWAN |
| 摘要: | Background: Pathogenic coronaviruses include Middle East respiratory syndrome coronavirus (MERS-CoV), severe acute respiratory syndrome coronavirus (SARS-CoV), and SARS-CoV-2. These viruses have induced outbreaks worldwide, and there are currently no effective medications against them. Therefore, there is an urgent need to develop potential drugs against coronaviruses. Methods: High-throughput technology is widely used to explore differences in messenger (m) RNA and micro (mi)RNA expression profiles, especially to investigate proteineprotein interactions and search for new therapeutic compounds. We integrated miRNA and mRNA expression profiles in MERS-CoV-infected cells and compared them to mock-infected controls from public databases. Results: Through the bioinformatics analysis, there were 251 upregulated genes and eight highly differentiated miRNAs that overlapped in the two datasets. External validation verified that these genes had high expression in MERS-CoV-infected cells, including RC3H1, NF-kappa B, CD69, TNFAIP3, LEAP-2, DUSP10, CREB5, CXCL2, etc. We revealed that immune, olfactory or sensory system-related, and signal-transduction networks were discovered from upregulated mRNAs in MERS-CoV-infected cells. In total, 115 genes were predicted to be related to miRNAs, with the intersection of upregulated mRNAs and miRNA-targeting prediction genes such as TCF4, NR3C1, and POU2F2. Through the Connectivity Map (CMap) platform, we suggested potential compounds to use against MERS-CoV infection, including diethylcarbamazine, harpagoside, bumetanide, enalapril, and valproic acid. Conclusions: The present study illustrates the crucial roles of miRNA- mRNA interacting networks in MERS-CoV-infected cells. The genes we identified are potential targets for treating MERS-CoV infection; however, these could possibly be extended to other coronavirus infections. Copyright (C) 2021, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. |
| 關聯: | J MICROBIOL IMMUNOL, v.54, n.5, pp.845-857 |
| 顯示於類別: | [生物科技系(所)] 期刊論文
|
文件中的檔案:
| 檔案 |
描述 |
大小 | 格式 | 瀏覽次數 |
|---|
| index.html | | 0Kb | HTML | 71 | 檢視/開啟 | | j.jmii.2021.03.007.pdf | | 3716Kb | Adobe PDF | 33 | 檢視/開啟 |
|
在CNU IR中所有的資料項目都受到原著作權保護.
|
